Quick Answer
LeonaBio, Inc. reported Diluted EPS of $24.70 per share (loss) for fiscal year 2025.
LeonaBio, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$24.70 | +1.9% |
| 2024 | -$25.19 | -715.2% |
| 2023 | -$3.09 | -22.1% |
| 2022 | -$2.53 | -69.8% |
| 2021 | -$1.49 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.68 | +77.5% | -833.3% |
| June 30, 2025 | -$0.18 | +74.3% | +21.7% |
| March 31, 2025 | -$0.23 | +66.7% | +96.9% |
| September 30, 2024 | -$7.46 | -757.5% | -965.7% |
| June 30, 2024 | -$0.70 | +10.3% | -1.4% |
| March 31, 2024 | -$0.69 | +5.5% | +20.7% |
| September 30, 2023 | -$0.87 | -64.2% | -11.5% |
| June 30, 2023 | -$0.78 | -20.0% | -6.8% |
- LeonaBio, Inc. showed an increase of +1.9% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, LeonaBio, Inc.’s diluted eps has declined by 1557.7% (from $1.49 per share (loss) to $24.70 per share (loss)).
- The most recent figure is from LeonaBio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: